Insider Selling: CME Group Inc (CME) CFO Sells 7,500 Shares of Stock
CME Group Inc (NASDAQ:CME) CFO John W. Pietrowicz sold 7,500 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $151.50, for a total transaction of $1,136,250.00. Following the completion of the sale, the chief financial officer now directly owns 32,376 shares in the company, valued at approximately $4,904,964. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of CME Group Inc (CME) traded up $0.90 on Wednesday, hitting $152.63. 944,700 shares of the company traded hands, compared to its average volume of 1,165,183. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $51,950.00, a P/E ratio of 34.61, a price-to-earnings-growth ratio of 2.55 and a beta of 0.72. CME Group Inc has a fifty-two week low of $113.90 and a fifty-two week high of $155.29.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million for the quarter, compared to the consensus estimate of $890.22 million. CME Group had a net margin of 40.94% and a return on equity of 7.89%. CME Group’s revenue was up 5.8% on a year-over-year basis. During the same quarter last year, the firm posted $1.05 earnings per share. equities research analysts expect that CME Group Inc will post 4.76 earnings per share for the current fiscal year.
The business also recently declared a dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Thursday, December 28th will be paid a dividend of $3.50 per share. The ex-dividend date is Wednesday, December 27th. This is an increase from CME Group’s previous dividend of $3.25. CME Group’s dividend payout ratio (DPR) is currently 59.86%.
Several brokerages recently issued reports on CME. Wells Fargo & Co upped their price objective on shares of CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. Royal Bank of Canada upped their price objective on shares of CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research note on Tuesday, December 19th. Barclays upped their price objective on shares of CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday, October 10th. Finally, Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective on the stock in a research note on Tuesday, January 2nd. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $144.22.
A number of large investors have recently bought and sold shares of CME. Janus Henderson Group PLC raised its stake in CME Group by 13,530.7% during the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock worth $770,227,000 after purchasing an additional 6,104,897 shares during the period. Fiera Capital Corp raised its stake in CME Group by 243.9% during the second quarter. Fiera Capital Corp now owns 1,926,918 shares of the financial services provider’s stock worth $241,327,000 after purchasing an additional 1,366,557 shares during the period. Capital International Investors raised its stake in CME Group by 11.4% during the third quarter. Capital International Investors now owns 12,489,045 shares of the financial services provider’s stock worth $1,694,514,000 after purchasing an additional 1,279,058 shares during the period. BT Investment Management Ltd purchased a new position in CME Group during the second quarter worth approximately $95,104,000. Finally, Atlantic Trust Group LLC raised its stake in CME Group by 1,943.2% during the third quarter. Atlantic Trust Group LLC now owns 606,942 shares of the financial services provider’s stock worth $82,349,000 after purchasing an additional 577,237 shares during the period. 82.70% of the stock is currently owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “Insider Selling: CME Group Inc (CME) CFO Sells 7,500 Shares of Stock” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/insider-selling-cme-group-inc-cme-cfo-sells-7500-shares-of-stock/1801345.html.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with Analyst Ratings Network's FREE daily email newsletter.